Cincinnati Children’s Investigator Idea May Lead to Answer to COVID-19 Deadly Cytokine Storm: Ruxolitinib

Cincinnati Children’s Investigator Idea May Lead to Answer to COVID-19 Deadly Cytokine Storm: Ruxolitinib

Cincinnati Children’s researchers initially developed a transgenic mouse to model HLH (hemophagocytic lymphohistiocytosis), a deadly childhood immune disease but as it now turns out this effort may end up saving lives during the COVID-19 pandemic. Cincinnati...
UC San Diego’s ACTRI Driving Results, $55m of New Funding & an Exciting Future for 8th Largest U.S. City

UC San Diego’s ACTRI Driving Results, $55m of New Funding & an Exciting Future for 8th Largest U.S. City

The Altman Clinical and Translational Research Institute (ACTRI) at University of California San Diego received a five-year, $54.7 million Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Science (NCATS), part of the...
New Jersey-based Hackensack Meridian Health a Force for COVID-19 Research Treating 1,000 Clinical Trial Patients

New Jersey-based Hackensack Meridian Health a Force for COVID-19 Research Treating 1,000 Clinical Trial Patients

Hackensack Meridian Health, a network of New Jersey-based health providers, reached a major milestone in serving as a COVID-19 clinical investigational center—treating 1,000 patients with the latest investigative treatments during the pandemic. From antiviral drugs to...
Prominent NYC Trust Awards $1.4m to Monash & Doherty Institute to Advance Ivermectin Research Targeting COVID-19

Prominent NYC Trust Awards $1.4m to Monash & Doherty Institute to Advance Ivermectin Research Targeting COVID-19

The growing interest in ivermectin as a possible treatment for patients infected with SARS-CoV-2, the virus behind the COVID-19 pandemic, was triggered by a laboratory experiment in a cell culture undertaken by Australian-based scientists at Monash University and the...
Atlantic Health System Transitions to ‘New Normal’ for Next Two Years: Will Clinical Trials go Partially Remote?

Atlantic Health System Transitions to ‘New Normal’ for Next Two Years: Will Clinical Trials go Partially Remote?

Recently, Atlantic Health System President and CEO Brian Gragnolati discussed the meaning of the “new normal” as the provider moves forward out of the worst of the pandemic. An important regional health system, the New Jersey-based, not-for-profit health system has a...

Pin It on Pinterest